Advanced Immunology & Specialized Kidney Disease Tests in Chandigarh
When Kidney Disease Needs More Than Routine Testing
Most kidney problems show up first through routine tests like creatinine, eGFR, and urine protein. However, once a nephrologist suspects an autoimmune cause, a transplant complication, or a rare condition affecting the kidneys directly, a different level of testing becomes necessary.
This guide covers the specialized immunology and diagnostic tests Altus Lab offers for patients already under a nephrologist’s care, including those managing glomerulonephritis, kidney transplants, or suspected blood disorders affecting the kidneys. If you are new to kidney testing, we recommend starting with our complete guide to routine kidney function tests before exploring the tests below.
Dr. Alok Gupta, MD Pathology, Ex-PGIMER Chandigarh, supervises every test here, and home collection is available for most tests across Chandigarh, Mohali, and Panchkula.
Complement C3 & C4
Complement C3 and C4 are proteins that play a central role in your immune system’s inflammatory response. In several kidney diseases, particularly those involving immune complex deposition, these complement levels drop noticeably, making them valuable diagnostic clues for your nephrologist.
Low C3 and C4 levels often point toward conditions like lupus nephritis, post-infectious glomerulonephritis, or membranoproliferative glomerulonephritis, each of which requires a distinctly different treatment approach. Consequently, doctors use complement testing not just to diagnose these conditions initially, but also to monitor disease activity over time.
For patients already diagnosed with an immune-related kidney condition, rising complement levels often signal that treatment is working, while persistently low levels may indicate ongoing disease activity. At Altus Lab, we process C3 and C4 together, since comparing both values gives your nephrologist far more diagnostic clarity than either marker alone.
ANCA (PR3 & MPO)
ANCA, or Anti-Neutrophil Cytoplasmic Antibodies, are autoantibodies associated with a group of serious conditions called ANCA-associated vasculitis, which can cause rapid, aggressive kidney damage if left untreated. This test specifically checks for two antibody types, PR3 and MPO, each linked to slightly different disease patterns.
Doctors order ANCA testing urgently when a patient presents with rapidly declining kidney function alongside symptoms like blood in urine, fatigue, or unexplained weight loss, since ANCA-associated vasculitis can progress to kidney failure within weeks if not caught early. Early diagnosis can genuinely change outcomes, making this one of the most time-sensitive tests in nephrology.
Beyond initial diagnosis, ANCA levels also help doctors monitor treatment response and detect disease relapse in patients already diagnosed. At Altus Lab, we understand the urgency behind this test and prioritize rapid processing, since delayed results can directly affect how quickly a patient receives potentially kidney-saving treatment.
Anti-GBM Antibody
Anti-GBM, or Anti-Glomerular Basement Membrane Antibody, detects a rare but severe autoimmune condition where the immune system directly attacks the kidney’s filtering membrane. This condition, sometimes called Goodpasture syndrome when it also affects the lungs, can cause devastating kidney damage extremely quickly.
Because Anti-GBM disease progresses so rapidly, often causing irreversible kidney failure within days, this test is ordered as a genuine medical emergency whenever a doctor suspects it, typically alongside ANCA testing since the two conditions can occasionally overlap. Patients presenting with sudden kidney failure combined with coughing up blood require this test immediately.
Given the severity and speed of this condition, Altus Lab prioritizes Anti-GBM testing for urgent processing whenever a nephrologist flags a case as time-sensitive. Early detection allows doctors to start aggressive treatment, including plasma exchange therapy, which can genuinely mean the difference between kidney recovery and permanent kidney failure.
Renal Transplant Immunosuppressant Drug Levels (Tacrolimus, Cyclosporine)
Kidney transplant patients take immunosuppressant medications like Tacrolimus or Cyclosporine for life, and getting the dose exactly right matters enormously. Too little medication risks organ rejection, while too much increases the risk of infection and drug toxicity, making precise blood level monitoring absolutely essential for every transplant recipient.
Unlike most medications, these drugs have a narrow therapeutic window, meaning the difference between an effective dose and a harmful one is relatively small. Consequently, transplant patients need regular blood level testing, often weekly in the early months after surgery, gradually reducing to monthly or quarterly testing as the transplant stabilizes.
At Altus Lab, we understand that transplant patients cannot afford delays or errors in this testing. Our laboratory processes these drug levels with strict accuracy protocols, and we coordinate closely with your transplant team to ensure results reach your nephrologist quickly enough to adjust dosing before your next medication cycle.
Urine Bence-Jones Protein
Urine Bence-Jones Protein detects abnormal light chain proteins that appear in urine, most commonly associated with multiple myeloma, a cancer affecting plasma cells in the bone marrow. When present, these proteins can also directly damage the kidneys, a condition called myeloma kidney or cast nephropathy.
Doctors order this test when a patient presents with unexplained kidney failure combined with other warning signs like bone pain, anemia, or elevated blood calcium, all of which can point toward an underlying blood disorder rather than primary kidney disease. Identifying Bence-Jones protein early allows treatment to begin before kidney damage becomes irreversible.
This test works best alongside blood-based tests like the Free Light Chain Assay and Multiple Myeloma Panel, since together they provide a more complete diagnostic picture than any single test. At Altus Lab, we often recommend ordering these tests as a combined panel when myeloma-related kidney disease is suspected.
PLA2R (Phospholipase A2 Receptor Antibody)
PLA2R Antibody testing represents a genuine breakthrough in diagnosing Membranous Nephropathy, a common cause of nephrotic syndrome in adults. Before this test existed, doctors often needed a kidney biopsy simply to identify the underlying cause of significant protein loss in urine. Today, a blood test can frequently provide that same answer.
About 70 percent of primary membranous nephropathy cases test positive for PLA2R antibodies, making this test useful for initial diagnosis and, importantly, for monitoring treatment response over time. Falling antibody levels typically predict clinical improvement, while persistently high levels suggest the disease remains active.
This test has genuinely changed how nephrologists manage membranous nephropathy, often reducing the need for repeat biopsies. At Altus Lab, PLA2R testing is available for patients with unexplained nephrotic-range proteinuria, offering a less invasive path toward diagnosis and ongoing disease monitoring.
ANA (Antinuclear Antibody)
ANA, or Antinuclear Antibody, is one of the most widely used screening tests for autoimmune disease. When positive, it suggests your immune system may be producing antibodies against your own cells, a pattern seen in conditions like lupus, which frequently affects the kidneys and can cause serious, long-term damage if left untreated.
Doctors typically order ANA testing when a patient has a combination of symptoms, including joint pain, unexplained rashes, fatigue, and kidney involvement, since these symptoms often point to a systemic autoimmune condition rather than an isolated kidney problem. A positive ANA result does not confirm a specific diagnosis on its own, but rather opens the door to further, more specific testing.
This is why ANA is often ordered alongside the ANA Blot Profile, which we cover next, since the combination helps your doctor narrow down which autoimmune condition may be responsible for your symptoms and kidney involvement.
ANA Blot Profile / ENA Profile
While ANA testing tells your doctor that an autoimmune process may be present, the ANA Blot Profile, also called the ENA Profile, identifies specifically which autoantibodies are involved. This distinction matters enormously, since different autoantibody patterns point toward different specific conditions, each requiring its own treatment approach.
This detailed panel tests for multiple specific antibodies, helping distinguish between conditions like lupus, Sjögren’s syndrome, and mixed connective tissue disease, several of which can significantly affect kidney function if left untreated. For patients with a positive ANA result, this follow-up panel becomes essential for reaching an accurate, actionable diagnosis.
At Altus Lab, we recommend this test as the natural next step whenever initial ANA screening comes back positive, particularly for patients with kidney involvement. Together, these two tests give your nephrologist and rheumatologist the detailed information needed to coordinate an effective, condition-specific treatment plan.
NT-proBNP
NT-proBNP may seem more associated with heart health than kidney health, yet the connection between the two organs runs deep, particularly in patients with chronic kidney disease. This test measures a hormone released when the heart is under increased strain, most commonly from fluid overload, a frequent complication of declining kidney function.
Kidney disease and heart disease are closely linked, since failing kidneys struggle to remove excess fluid and sodium, placing additional strain on the heart over time. Consequently, nephrologists often order NT-proBNP alongside routine kidney tests to assess whether fluid overload contributes to symptoms such as breathlessness or swelling.
This test also helps distinguish between kidney-related fluid retention and primary heart failure, two conditions that can present with remarkably similar symptoms. At Altus Lab, NT-proBNP testing gives your nephrologist essential information for managing the heart-kidney relationship, which becomes increasingly important as kidney disease progresses.
Multiple Myeloma Panel (Serum Electrophoresis)
Serum Protein Electrophoresis separates the different proteins in your blood into distinct bands, allowing doctors to detect abnormal protein patterns associated with multiple myeloma and related blood disorders. When myeloma is present, this test typically reveals a characteristic spike, called an M-spike, caused by abnormal antibody production.
This panel becomes particularly relevant for kidney patients because myeloma frequently causes kidney damage, sometimes as the very first sign that leads to diagnosis. Doctors often order this test when unexplained kidney failure occurs alongside symptoms like bone pain, anemia, or elevated blood calcium, all classic warning signs of myeloma.
At Altus Lab, this panel works best when combined with Urine Bence-Jones Protein and the Free Light Chain Assay, since myeloma can sometimes be missed if only one of these three tests is performed. Together, this combination offers nephrologists the most complete picture when myeloma-related kidney disease is suspected.
Free Light Chain Assay
The Free Light Chain Assay measures small protein fragments produced by plasma cells, offering a highly sensitive way to detect abnormal antibody production, even when serum electrophoresis and Bence-Jones Protein testing come back normal or inconclusive. This makes it particularly valuable for early or borderline cases.
Beyond initial diagnosis, this test plays a crucial role in monitoring treatment response for patients already diagnosed with multiple myeloma or related kidney-affecting conditions. Because free light chains clear through the kidneys, this test also helps doctors understand how myeloma and kidney function interact over time.
At Altus Lab, we recommend this test whenever a nephrologist has strong clinical suspicion of a plasma cell disorder, even if other initial tests appear normal. Its higher sensitivity often catches cases that might otherwise be missed, making it an essential addition to any complete myeloma-related kidney workup.
Anti-CCP Antibody
Anti-CCP, or Anti-Cyclic Citrullinated Peptide Antibody, is primarily known as a highly specific marker for rheumatoid arthritis. However, its relevance to nephrology comes from the fact that rheumatoid arthritis, and the medications used to treat it, can sometimes affect kidney function, making this test relevant for patients with overlapping joint and kidney symptoms.
Doctors may order Anti-CCP testing when a kidney patient also presents with joint pain, stiffness, or swelling, helping determine whether an underlying autoimmune condition like rheumatoid arthritis might be contributing to their overall clinical picture. This test is notably more specific than older rheumatoid markers, reducing the chance of a misleading result.
At Altus Lab, Anti-CCP testing is often ordered as part of a broader autoimmune workup for kidney patients with joint symptoms, helping your nephrologist and rheumatologist coordinate care effectively when multiple organ systems appear to be involved simultaneously.
How to Book Advanced Nephrology Testing at Altus Lab
Many of these specialised tests are time-sensitive, particularly ANCA and Anti-GBM antibody testing. Call or WhatsApp our team directly, and share your prescription so we can confirm which tests you need and prioritise urgent cases appropriately.
📞 Call: 0172-5017001 / 0172-5017002
💬 WhatsApp: +91-62842-14977
📍 SCO 35, Sector 16-D, Chandigarh
🕐 Open 7 Days: 7:30 AM – 9:30 PM
Home sample collection is available for most tests across Chandigarh, Mohali, and Panchkula. For transplant patients requiring regular drug level monitoring, ask our team about scheduling recurring appointments.
Frequently Asked Questions
1. What is the difference between ANCA and Anti-GBM testing?
ANCA detects antibodies linked to vasculitis affecting small blood vessels, while Anti-GBM detects antibodies specifically attacking the kidney’s filtering membrane. Both cause rapid kidney damage, and doctors sometimes order them together when the clinical picture is unclear.
2. How often do transplant patients need drug level testing?
Testing frequency varies by transplant stage, often weekly in the first few months after surgery, then gradually reducing to monthly or quarterly once levels stabilize. Your transplant team will guide the exact schedule for your situation.
3. Does a positive PLA2R test replace the need for a kidney biopsy?
In many cases of suspected membranous nephropathy, a positive PLA2R result can support diagnosis without an immediate biopsy. However, your nephrologist makes this decision based on your complete clinical picture.
4. Why would I need both Serum Electrophoresis and Free Light Chain testing?
Free Light Chain testing is more sensitive and can catch cases that Serum Electrophoresis alone might miss, particularly in early or borderline myeloma-related kidney disease. Together, they provide more complete diagnostic coverage.
5. Is ANA testing only relevant for lupus?
No. While lupus is a common cause of a positive ANA, this test broadly screens for autoimmune activity, and the ANA Blot Profile then helps narrow it to a more specific diagnosis.
6. How urgent is ANCA or Anti-GBM testing?
Both tests are considered urgent, since the conditions they detect can cause irreversible kidney damage within days to weeks. Altus Lab prioritizes rapid processing whenever a doctor flags these as time-sensitive.
7. Can Anti-CCP testing detect kidney disease directly?
No. Anti-CCP specifically detects rheumatoid arthritis-related antibodies. It becomes relevant to kidney patients only when joint symptoms suggest rheumatoid arthritis may be contributing to their overall condition.
8. Do I need a doctor’s referral for these specialized tests?
While walk-in testing is possible for some tests, we strongly recommend a nephrologist’s guidance for these specialized panels, since correct interpretation often requires clinical context that only your treating doctor can provide.